Semax Side Effects: What Is Reported vs Theoretical

Semax Side Effects: Reported vs Theoretical

Here is the short version. The licensed Russian nasal-drop labels list almost nothing: mild irritation of the nasal lining with prolonged use on one label, restlessness and insomnia on the other. Small studies and user reports add headache, dizziness, fatigue and trouble sleeping. Everything else you will read about, bleeding, immune reactions, abnormal brain-wave activity, dependence, cancer, is a hypothesis drawn from animal work or from how peptides behave in general. The evidence behind all of it is thin and mostly Russian, and the FDA's 2026 evaluation could not find a single human safety study of Semax given by injection, which is the only way it is prescribed in the United States.

Semax is not an FDA-approved drug and is not an approved treatment for anxiety, depression, ADHD or any other mental-health condition. That sentence matters for a safety page because much of what gets sold online as Semax is marketed on exactly those promises. The table grades each effect or risk by where it comes from. "Label" means a Russian product label. "Study" means a published trial or series, almost always small and open-label. "Anecdotal" means user reports and secondary sources with no measurement behind them. "Theoretical" means nobody has looked in people.

A few things turn up in forums that are not in the table: a metallic taste, flushing, a tight feeling in the chest. They are anecdotal, with no timing or frequency attached, and they are listed here only so you know they have been described. If one of them happens to you, it belongs in a message to the prescriber, not in a mental note to push through.

Semax/Selank

The only form of Semax PeRx prescribes: Semax and Selank together in one 5 mL vial, 1 mg/mL of each, compounded by a state-licensed 503A pharmacy and injected under the skin. The vial ships fully reconstituted and ready to use.

A licensed provider reviews every prescription against the screening questions on this page before the pharmacy fills it, and dose steps are decided at each renewal check-in. From $299 for a one-month supply. The blend is not an FDA-approved drug.

One vial, both peptides, subcutaneous. There is no nasal product.

Check eligibility

What Semax Is, and Why the Route Matters for Safety

Semax is a synthetic seven-amino-acid peptide built from a fragment of ACTH, the pituitary stress hormone, with the hormonal activity engineered out and the effects on attention and memory kept in. It was developed in Moscow and is licensed in Russia as nasal drops, in 0.1% and 1% strengths, for uses that include stroke recovery, cognitive impairment after brain injury and optic nerve disease. It is not approved by the FDA or by any European regulator. Our complete Semax guide Read nextSemax Peptide: What It Is, Uses, and the EvidenceSemax is a seven-amino-acid peptide designed in Moscow, registered in Russia as nasal drops, and sold in the United States mostly by chemical suppliers. This guide covers what it is, what the studies in rats and in people actually show, what FDA reviewers concluded in 2026, who gets screened out, and why PeRx prescribes it only inside an injected blend with Selank.Read article covers the history and the research; this page stays on safety.

The route matters because the safety record, such as it is, belongs to the nasal drops. Every human study the FDA could find used the intranasal route. The product prescribed in the United States, including by PeRx, is a subcutaneous injection, and the FDA wrote plainly that it found no safety data for Semax given that way. So the injected form borrows the nasal record for reassurance and adds the unknowns of a different route, a different absorption profile and a compounded vial. Keep that in mind each time this page says "reported": reported for the drops, in Russia, in small numbers.

Semax Side Effects in Studies and on the Label

What the Russian labels list

The two labels do not say the same thing, which is itself worth knowing. The 1% label, from the manufacturer Peptogen and dated June 2011, lists one side effect: slight irritation of the nasal lining with prolonged use. Its contraindications are hypersensitivity, acute psychotic states, disorders accompanied by anxiety, pregnancy, breastfeeding and a history of convulsions. The older 0.1% label, from a 2003 instruction, lists excitation and insomnia as side effects, and its contraindications add endocrine disease and children under five. Both warn against using nasal decongestant sprays alongside the drops.

Statements on those labels that Semax is "practically non-toxic" rest on animal testing and on the manufacturer, not on large human safety trials. A label that lists one side effect is not evidence that there is one side effect. It is evidence that the registration studies were small, open-label and not designed to count adverse events, which is what the FDA concluded when it went looking.

Peptogen (ZAO INPC Peptogen). Semax 1% nasal drops, instructions for medical use, dated June 1, 2011. Reproduced at medi.ru. Contraindications: hypersensitivity, acute psychotic states, anxiety-accompanied disorders, pregnancy, lactation, history of convulsions. Side effect: slight nasal mucosa irritation with prolonged use. View study

Semax 0.1% nasal solution, instructions for medical use approved July 31, 2003. Reproduced in the RLS drug register (entry updated November 21, 2018). Contraindications include hypersensitivity, acute psychotic states, anxiety disorders, endocrine disease, pregnancy, breastfeeding and age under 5. Side effects: excitation, insomnia. View study

What human studies reported

Ahead of its July 2026 advisory meeting, FDA staff tallied every published human exposure they could assess: between 33 and 47 healthy adults, 69 adults with medical conditions (chronic ischemic brain disease, migraine and trigeminal nerve pain, peptic ulcer), and 451 children with depression or tic disorders. Three of the eight references were meeting abstracts with no full paper. One reference, a 1996 study of 37 adults with facial pain, reported that no adverse events were seen. The other seven did not discuss adverse events at all. In several, Semax was given alongside other drugs or therapies, so nothing could be attributed to it even if it had been recorded.

That is the entire measured human safety record in the English-language literature, and the FDA described it as insufficient to characterize a safety profile. Small, short, mostly open-label studies that do not count side effects are not a reassuring safety signal. They are an absence of a signal. The one human finding that does bear on safety, seizure-like EEG activity in a 1999 series, sits in the theoretical section below because it was a small observation in brain-injured patients, not a measured rate.

U.S. Food and Drug Administration. FDA Briefing Document: Semax-Related Bulk Drug Substances (Semax (free base) and Semax acetate). Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026. Evaluation dated May 11, 2026, safety section. View study

Effects people report

Across user forums and vendor pages the same list repeats: nasal irritation, burning, congestion or a runny nose after the drops; headache; trouble falling asleep or staying asleep; restlessness or a wired, anxious edge; nausea; dizziness. Every one of those is a report, not a rate. No controlled study has measured how often any of them happens, and none of the secondary sources that list them cite a study that did. We do not offer tips for managing them here, because a side effect you are managing on your own is a side effect your prescriber has not heard about.

Blood sugar and nasal discoloration

Two figures circulate as if they were measured rates. A 2013 Russian review, as summarized by the Alzheimer's Drug Discovery Foundation in its 2020 researcher report, gives discoloration of the nasal cavity in about 10% of patients using the drops and a rise in blood glucose in about 7.4% of patients with diabetes. The foundation could not check the review against original data, and neither could we; the review is not indexed in PubMed. The nasal finding is a nasal-route effect and does not transfer to an injection. The glucose finding might, which is why diabetes is on the screening list. Both numbers are given here as reported, and neither was measured by PeRx.

Alzheimer's Drug Discovery Foundation. Semax. Cognitive Vitality Report for Researchers, June 2020. Safety section: "Little human evidence exists for potential side effects"; nasal cavity discoloration (~10%) and increased blood glucose in diabetics (~7.4%) cited to Kolomin et al. 2013; long-term side effects unknown. View study

For the reactions common to every injected peptide, redness or a small lump at the injection site, bruising, the rare infection from poor technique, our peptide side effects guide Read nextPeptide Side Effects: Normal vs. Red Flag (2026)Most peptide side effects are mild local reactions that resolve in a day. A smaller set of systemic effects depends on the pathway the peptide acts on. And a third category, the one worth paying attention to, points to a problem with the product or the patient that should pause the protocol. Here is how to tell them apart.Read article covers what is normal and what is not.

Theoretical Risks and Unknowns

None of the five risks in this section has been observed as a side effect in people. Each is here because an animal study, a mechanism or a gap in the record makes it worth screening for. That is the right way to read them: reasons for caution in specific groups, not findings.

Bleeding

In rats, Semax given intranasally for several days increased the anticoagulant and clot-dissolving activity of the blood, and treated animals formed smaller clots when a vein was clamped. A second rat study found anticoagulant and antiplatelet effects under stress. No human study has measured any of it. The FDA wrote that these findings raise concern about the risk of bleeding, particularly in people already at risk or taking medicines that increase bleeding, and that a compounded product carries no label to warn them. Treat it as preclinical, and as a hard stop for anyone on a blood thinner until a clinician says otherwise.

Cherkasova KA, Lyapina LA, Ashmarin IP. Comparative study of modulatory effects of Semax and primary proline-containing peptides on hemostatic reactions. Bull Exp Biol Med. 2001;132(1):625-628. PMID: 11687836 View study

Grigorjeva ME, Lyapina LA. Anticoagulation and antiplatelet effects of semax under conditions of acute and chronic immobilization stress. Bull Exp Biol Med. 2010;149(1):44-46. PMID: 21113455 View study

Immune reactions and impurities

Any peptide can prompt the body to make antibodies against it, and peptides that clump into aggregates, or that carry manufacturing impurities, do so more readily. The FDA raised both concerns for Semax in injectable and nasal-spray form and noted that neither nomination supplied impurity, aggregate or endotoxin testing data. No study has checked immunogenicity for Semax by any route. This is the risk most tied to who made the vial, which is why the sourcing section below exists.

EEG changes and seizures

A 1999 Russian series followed 73 patients with brain damage after oxygen deprivation, 14 of them in a persistent vegetative state. The authors reported that in some cases the EEG showed episodes of paroxysmal, seizure-like activity after Semax, and advised that the first dose be given with brain-wave monitoring. It says nothing about how often this happens, nothing about healthy people, and the abstract does not specify the route. It is the reason both Russian labels list a history of convulsions as a contraindication, and the reason a seizure history is a firm no on the PeRx screening.

Alekseeva GV, Bottaev NA, Goroshkova VV. [Use of semax at a follow-up of patients with posthypoxic encephalopathy]. Anesteziol Reanimatol. 1999;(1):40-43. Russian. PMID: 10199046 View study

Abuse potential and stimulant medicines

In rats, Semax given before D-amphetamine produced a larger surge of dopamine in the striatum than amphetamine alone, and in mice it increased amphetamine-driven movement. The striatal dopamine surge is the response that drugs of abuse such as cocaine produce, which is why the FDA flagged abuse potential as an open question and noted that no study has addressed it. There is no human evidence that Semax is habit-forming, and no human study of how it interacts with prescribed stimulants such as Adderall, Vyvanse or methylphenidate. Both facts cut the same way: nobody knows, so the combination is screened for.

Eremin KO, Saransaari P, Oja S, Raevskii KS. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice]. Eksp Klin Farmakol. 2004;67(2):8-11. Russian. PMID: 15188751 View study

Cancer and long-term safety

The only long-term animal study gave Semax to female SHK mice, a strain bred to develop mammary tumors early and die young. Treated mice ended life with smaller tumors and lived longer, and the authors suggested an anti-cancer effect. The FDA was unmoved: one fixed dose, females only, treatment short relative to lifespan, and a strain that cannot answer the question a carcinogenicity study asks. No standard long-term cancer study exists. The FDA also found no acute toxicity, repeat-dose toxicity or reproductive toxicity studies of any kind. Long-term human safety is unknown, which is a different statement from safe.

Meshavkin VK, Kost NV, Sokolov OY, et al. The influence of oligopeptides on spontaneous carcinogenesis in mice. Dokl Biol Sci. 2013;449:68-70. PMID: 23652432 View study

Our page on peptides and long-term safety Read nextAre Peptides Safe Long-Term? What the Data SaysMost safety questions about peptides assume the timeframe is one or two cycles. The harder question is what happens after a year, three years, or a decade. The honest answer is that peptides fall into three buckets: ones with multi-decade clinical data, ones with several years of safety record but limited long-term studies, and ones where the long-term picture is genuinely incomplete. Here is the bucket each peptide is in and what monitoring matters.Read article explains why "no data" and "no risk" get confused so often, and what a prescriber can and cannot do about the gap.

Anxiety, Sleep and Overstimulation

Semax is usually described as activating, not calming, and the labels agree. The 0.1% label lists excitation and insomnia as its side effects, and both labels list acute psychotic states and disorders accompanied by anxiety as contraindications. In plain terms, the Russian regulator tells people with an anxiety disorder not to use it. In rodents Semax activates dopamine and serotonin systems, which fits the stimulating reputation and is the basis for caution with psychiatric medicines that act on the same systems.

Sleep trouble, irritability and restlessness are reported effects, not measured ones. Timing is the usual explanation offered online, and timing is a decision for the prescriber, not for this page. What this page will say is that Semax is not an approved treatment for anxiety, depression or ADHD anywhere outside its Russian indications, and that nobody with a diagnosed anxiety or mood disorder should treat it as one. Our comparison of Semax vs Selank Read nextSemax vs Selank: Which One Do You Actually Need?Every page ranking for this question tells you to pick one: Semax for focus, Selank for calm. The split is useful and softer than the marketing admits. Here is what the single human head-to-head found, where the two run on the same machinery, where the FDA record splits them, and why a prescribing clinic puts both in one vial instead of making you choose.Read article explains why the two peptides are paired at PeRx, with Selank studied for the calmer side of the pairing.

Eremin KO, Kudrin VS, Saransaari P, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005;30(12):1493-1500. PMID: 16362768 View study

Selank Side Effects

Selank is a synthetic seven-amino-acid peptide based on the immune peptide tuftsin, developed by the same Moscow institute as Semax and studied in Russia for anxiety-related effects, most often as a nasal preparation. Its English-language safety record is thinner than Semax's. Two Russian trials are the core: a 2008 study of 62 patients with generalized anxiety disorder or neurasthenia that compared Selank with the benzodiazepine medazepam, and a 2014 study of 60 patients with anxiety and somatoform disorders that compared it with phenazepam and rated tolerability on a standard scale. Both describe Selank as tolerated. Neither abstract itemizes side effects or gives a rate for any of them.

The FDA's position is shorter still. Selank acetate was nominated for the compounding bulks list and the nomination was withdrawn; the FDA's safety-risk page, current as of April 22, 2026, keeps it in the withdrawn table with the note that compounded Selank may carry immunogenicity risk by some routes because of aggregation and peptide impurities, and that the agency lacks important information regarding any safety issues raised by Selank acetate administered to humans. What users report overlaps with Semax: fatigue or drowsiness rather than restlessness, occasional headache, nasal irritation with the drops. Those are reports. The honest evidence grade for every Selank side effect is anecdotal or unknown, and the honest grade for its long-term safety is unknown. Our Selank guide Read nextSelank Peptide: What It Is, What It Does & BenefitsYour immune system already makes a molecule that calms anxiety. Soviet scientists found it in the 1970s, reverse-engineered it, and created two peptides: one that quiets anxiety without sedation, and another that sharpens cognition through BDNF. Both have been prescription medications in Russia since 2009. Combined in a single injectable blend, Selank and Semax cover both sides of the equation: calm and sharp at the same time.Read article and where to inject Selank Read nextWhere to Inject Semax/Selank: Sites, Rotation, TimingPeRx sells Selank as part of the Semax/Selank blend, a single vial given as a subcutaneous injection. Standalone intranasal Semax is a different product. This guide covers where to place the blend, how to rotate sites, and why morning timing matters, as of July 2026.Read article cover the rest.

Zozulia AA, Neznamov GG, Siuniakov TS, et al. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. Russian. PMID: 18454096 View study

Medvedev VE, Tereshchenko ON, Israelian AIu, et al. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(7):17-22. Russian. PMID: 25176261 View study

U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. Withdrawn-nominations table entries for Semax (heptapeptide) and Selank acetate (TP-7). Content current as of April 22, 2026. View study

Semax and Selank Side Effects Together

No published study describes the safety of Semax and Selank taken together. The rationale for pairing them is mechanistic, one activating and one calming, and it comes from prescribing practice rather than from a trial of the combination. The only responsible assumption is that the effects and cautions of each apply to the pair, and that an effect you cannot assign to one peptide still counts. The PeRx product contains both in one vial, 1 mg/mL of each, as listed on the product page Explore PeRxSemax/SelankCognitive Clarity & Calm FocusView peptide . A licensed provider reviews the prescription against the screening below, and our Semax vs Selank Read nextSemax vs Selank: Which One Do You Actually Need?Every page ranking for this question tells you to pick one: Semax for focus, Selank for calm. The split is useful and softer than the marketing admits. Here is what the single human head-to-head found, where the two run on the same machinery, where the FDA record splits them, and why a prescribing clinic puts both in one vial instead of making you choose.Read article comparison explains how the two differ.

Who Should Avoid Semax

This list combines the Russian label contraindications with the gaps the FDA identified. It is not exhaustive, and it is the list a prescriber works through, not a self-screen that replaces one. Each entry gives the reason, so you can see which are label rules and which are caution standing in for data.

Drug-tested athletes have a separate question. Semax is not on the WADA prohibited list by name, but the list reaches beyond names, and our injury recovery page carries the full disclosure for tested competitors, with the detail in do peptides show up on a drug test Read nextDo Peptides Show Up on a Drug Test?The short answer for most people is no. Standard employment and DOT drug screens do not test for therapeutic peptides. Anti-doping testing in competitive sport is a separate system with dedicated peptide detection, and that is where the answer changes. Here is the honest, clinic-side breakdown of who is tested, for what, and what it means if you are prescribed peptides.Read article . If you are unsure whether something on this list applies to you, our page on what providers review before prescribing peptides Read nextWhat Providers Review Before Prescribing PeptidesWhen your intake reaches a licensed provider, it is not a rubber stamp. There is a specific list they run down before any peptide is approved: the conditions that change whether a peptide is safe, the medication classes that have to be cross-checked, and the reasons an order gets sent back or declined. Here is that list, from the provider’s side of the screen.Read article shows how the screening works.

Product Quality and Sourcing Risks

Most Semax sold online is not the licensed Russian drop. It is a "research use only" powder or spray from a seller that is not a pharmacy, with no approval for human use and no outside check on concentration, purity or sterility. The one adverse event in the FDA's database, eye pain and burning that sent a consumer to hospital, followed 0.1% drops bought online from a research-chemical seller. The FDA also pointed out that the two compounding nominations it reviewed could not even agree on which chemical form of Semax they meant, free base or acetate salt, and that neither supplied impurity or endotoxin testing. For a peptide whose main theoretical risk is an immune reaction to impurities, the identity of the manufacturer is a safety variable.

A prescription filled by a state-licensed pharmacy with potency, sterility and endotoxin testing on each lot addresses the sourcing problem. It does not create human safety data for Semax, and it would be dishonest to imply that it does. Our quality testing page lists what is tested and why, and is it safe to buy peptides online Read nextIs It Safe to Buy Peptides Online?The honest answer is that it depends entirely on the source. "Buying peptides online" covers two opposite things: unregulated research-chemical websites, and licensed telehealth backed by a real provider and an FDA-regulated pharmacy. One of those is safe. This guide shows you how to tell them apart.Read article walks through how to tell a pharmacy from a vendor.

FDA Status: Where Semax Stands

U.S. Food and Drug Administration. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee. Event page with briefing documents, final agenda and FDA presentations. Content current as of August 6, 2026. View study

When to Get Medical Help

Mild redness at the injection site, a brief headache or a restless first night are the kind of thing to mention at the next check-in rather than an emergency. Our guide to peptide safety monitoring Read nextPeptide Safety Monitoring: Signals During TherapyThe most important safety tool on peptide therapy is your own attention. Most peptides are well tolerated, and the side effects people do notice are usually mild and easy to read once you know what is normal, what is worth mentioning, and what means stop and call your provider. This guide is about understanding your body on a peptide: the common symptoms, where your limits are, and when to reach out.Read article explains what to track between check-ins and what a prescriber wants to hear about.

Questions to Ask Your Provider

Four questions cover most of it. Does anything on the avoid list apply to me, including a seizure, a psychiatric diagnosis or a bleeding problem I might not have thought to mention? Could Semax interact with a stimulant, a blood thinner, an antidepressant or anything else I take? Which symptoms mean I should stop and call, and which can wait for the check-in? And is there an approved option with better safety data that fits what I am trying to fix? That last one is a fair question to ask any prescriber of any peptide, and our page on whether peptide therapy is safe Read nextIs Peptide Therapy Safe? What the Research ShowsPeptides are often marketed as if side effects do not exist. They are also dismissed by skeptics as unregulated and dangerous. The truth sits between those two positions. Here is what the published research says about the safety profile of therapeutic peptides, what the real risks are, and how sourcing affects everything.Read article is built around it.

Getting Semax/Selank Through a Prescription

The path at PeRx is short. You complete an online eligibility check that asks the screening questions on this page. A licensed provider reviews it and, if the blend fits, writes the prescription; your card is charged only after that approval. A state-licensed 503A pharmacy fills it and ships the vial ready to use, with syringes and swabs. Dose steps are decided at each renewal check-in, and PeRx does not order labs, so any blood work you want is a conversation with your own doctor. The blend is a compounded product and is not FDA approved. Our guide to how to get peptides prescribed online Read nextHow to Get Peptides Prescribed OnlineThere is a legitimate way to get peptides prescribed through telehealth, and there is a gray market that skips the medicine entirely. This guide walks the real path step by step: the online assessment, the licensed provider who reviews it, the US compounding pharmacy that prepares your peptide, and the box that arrives ready to use. It also shows you how to spot the sites you should walk away from.Read article covers the mechanics, and the nootropic peptides page lists everything in the category.

Semax and Selank Safety: Common Questions